The Latest Breaking News from TGA

Recalled Philips sleep apnoea devices posed dangers for users inhaling or ingesting small pieces of foam due to degradation, a government lawsuit claims.

This week, Australia’s Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease.

The BitMEX founder thinks a spending spree by the U.S. Treasury will help lift the price of Bitcoin.

More Australians than ever are being prescribed medicinal cannabis.

While Australia was busy defending the Pharmaceutical Benefits Scheme against threats from the United States in recent weeks, another issue related to the supply and trade of medicines was flying under the radar.

Despite social media hype, there is little evidence that the therapies, marketed as pills, shots and IV infusions, have any effects on ageing

More than half a century after its release, Hollywood continues to pay its dues to 'Airport,' the grandaddy of the modern disaster movie.

The healthcare complaints watchdog says at least two unnamed Sydney practitioners, allegedly posing as accredited medical professionals, are under investigation

TGA approved new indication for semaglutide drug in December 2024, but allocation to PBS still to be decided

The federal government yesterday released its response to the Senate inquiry into issues related to menopause. The inquiry recommended the government examine options to make menopause hormone therapy (MHT, or sometimes called hormone replacement therapy) more affordable and accessible, and address drug shortages.

Changes are coming into effect from February 1 about how paracetamol is sold in Australia.